Epic Sciences has appointed Murali Prahalad as President and CEO. Prahalad joins Epic from Life Technologies where he was vice president of corporate strategy and helped shape investment priorities in research tools, clinical diagnostics, and applied markets.
The National Cancer Institute has appointed Stephen Chanock to be director of NCI’s Division of Cancer Epidemiology and Genetics and a scientific director of the institute.
Chanock takes over DCEG from founding Director Joseph Fraumeni, who stepped down from the post a year ago.
Chanock formerly was a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in NCI’s Center for Cancer Research, he was co-chair of NCI’s Genetics, Genomics, and Proteomics Faculty, and he was chief of the Cancer Genomics Research Laboratory and the Laboratory of Translational Genomics. He also was acting director of the NCI Center for Cancer Genomics from 2012 to 2013.